|
FEM1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.122110E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.785400E-01 |
| Normal-vs-Stage2 |
2.025900E-02 |
| Normal-vs-Stage3 |
1.159680E-04 |
| Normal-vs-Stage4 |
5.59869999999796E-05 |
| Stage1-vs-Stage2 |
1.185620E-02 |
| Stage1-vs-Stage3 |
3.40249999997155E-06 |
| Stage1-vs-Stage4 |
2.01289999999243E-05 |
| Stage2-vs-Stage3 |
4.824800E-01 |
| Stage2-vs-Stage4 |
3.930000E-01 |
| Stage3-vs-Stage4 |
7.726200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.983600E-03 |
| Normal-vs-AfricanAmerican |
4.604800E-01 |
| Normal-vs-Asian |
1.028430E-01 |
| Caucasian-vs-AfricanAmerican |
2.504400E-01 |
| Caucasian-vs-Asian |
5.630800E-01 |
| AfricanAmerican-vs-Asian |
3.554800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.020100E-04 |
| Normal-vs-Female |
7.436200E-01 |
| Male-vs-Female |
8.05160000000305E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.314200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.237600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.546200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.102200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.731600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.603000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.871800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.992200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.728010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.320200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.844100E-02 |
| Normal-vs-Grade 2 |
6.229000E-01 |
| Normal-vs-Grade 3 |
8.840300E-04 |
| Normal-vs-Grade 4 |
2.39340000041111E-07 |
| Grade 1-vs-Grade 2 |
8.109900E-02 |
| Grade 1-vs-Grade 3 |
1.224410E-03 |
| Grade 1-vs-Grade 4 |
2.09829999999744E-05 |
| Grade 2-vs-Grade 3 |
1.572850E-04 |
| Grade 2-vs-Grade 4 |
4.36449999474675E-08 |
| Grade 3-vs-Grade 4 |
1.554470E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.438600E-01 |
| Normal-vs-ccB subtype |
3.99180000000277E-05 |
| ccA subtype-vs-ccB subtype |
1.44359999509902E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.922000E-03 |
| Normal-vs-N1 |
1.582460E-02 |
| N0-vs-N1 |
3.400600E-01 |
|
|
